The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence

The outbreak of emerging infectious pneumonia caused by 2019 Novel Coronavirus (2019-nCoV) has posed an enormous threat to public health, and traditional Chinese medicine (TCM) have made vast contribution to the prevention, treatment and rehabilitation of coronavirus disease 19 (COVID-19) among Chin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dan, Zhang, Bing, Lv, Jin-Tao, Sa, Ri-Na, Zhang, Xiao-Meng, Lin, Zhi-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198419/
https://www.ncbi.nlm.nih.gov/pubmed/32380051
http://dx.doi.org/10.1016/j.phrs.2020.104882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198419/
https://www.ncbi.nlm.nih.gov/pubmed/32380051
http://dx.doi.org/10.1016/j.phrs.2020.104882

Ejemplares similares